Skip to main content

Research Repository

Advanced Search

ATLAS: A Randomized Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis

People Involved

Status Project Complete
Funder(s) Hull University Teaching Hospitals NHS Trust
Value £5,937.00
Project Dates Jun 1, 2019 - Jan 31, 2022

You might also like

MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness Mar 1, 2019 - Feb 29, 2024
A parallel group, double-blind, randomised placebo-controlled trial comparing the efficacy and cost effectiveness of low dose oral modified release morphine (MRM) versus placebo on the intensity of breathlessness and daily activity in people with c... Read More about MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness.